Ability of wild type mouse bioassay to detect bovine spongiform encephalopathy (BSE) in the presence of excess scrapie

Bovine spongiform encephalopathy: A review of current knowledge and challenges

Bovine spongiform encephalopathy (BSE), also referred to as mad cow disease, is a chronic degenerative disease that affects the central nervous system. BSE is caused by a misfolded isoform of the prion protein, a widely expressed glycoprotein. The illness is referred to as Variant Creutzfeldt-Jakob disease (vCJD) in humans. In the United Kingdom (UK), BSE in cattle was first discovered in 1986. Based on epidemiological data, it appears that animal feed containing tainted meat and bone meal (MBM) as a source of meat protein is the common cause of the BSE outbreak in the UK. Clinical indicators in cows include irregular body posture, incoordination, difficulty in standing, weight loss, and temperamental changes, including agitation and hostility. Feeding livestock MBM obtained from BSE-infected livestock contaminated with BSE prions is the only known risk factor for BSE development. Strong evidence linking BSE to human transmission and a variant type of CJD has brought the disease to the attention of many countries. Screening living animals for BSE is challenging. In most cases, suspected animals are usually killed. Typically, the central nervous system is examined for prions to diagnose this illness. There is currently no robust treatment for BSE. The prevention of BSE can be achieved by avoiding the feeding of susceptible animals with ruminant tissues that might carry prions.

Bovine spongiform encephalopathy: A review of current knowledge and challenges

Bovine spongiform encephalopathy (BSE), also referred to as mad cow disease, is a chronic degenerative disease that affects the central nervous system. BSE is caused by a misfolded isoform of the prion protein, a widely expressed glycoprotein. The illness is referred to as Variant Creutzfeldt-Jakob disease (vCJD) in humans. In the United Kingdom (UK), BSE in cattle was first discovered in 1986. Based on epidemiological data, it appears that animal feed containing tainted meat and bone meal (MBM) as a source of meat protein is the common cause of the BSE outbreak in the UK. Clinical indicators in cows include irregular body posture, incoordination, difficulty in standing, weight loss, and temperamental changes, including agitation and hostility. Feeding livestock MBM obtained from BSE-infected livestock contaminated with BSE prions is the only known risk factor for BSE development. Strong evidence linking BSE to human transmission and a variant type of CJD has brought the disease to the attention of many countries. Screening living animals for BSE is challenging. In most cases, suspected animals are usually killed. Typically, the central nervous system is examined for prions to diagnose this illness. There is currently no robust treatment for BSE. The prevention of BSE can be achieved by avoiding the feeding of susceptible animals with ruminant tissues that might carry prions.

Incomplete inactivation of atypical scrapie following recommended autoclave decontamination procedures

Prions are highly resistant to the decontamination procedures normally used to inactivate conventional pathogens. This is a challenging problem not only in the medical and veterinary fields for minimizing the risk of transmission from potentially infective sources but also for ensuring the safe disposal or subsequent use of animal by-products. Specific pressure autoclaving protocols were developed for this purpose, but different strains of prions have been reported to have differing resistance patterns to established prion decontamination procedures, and as additional TSE strains are identified it is necessary to determine the effectiveness of such procedures. In this study we assessed the efficacy of sterilization using the EU recommended autoclave procedure for prions (133°C, 3 Bar for 20 min) on the atypical or Nor98 (AS/Nor98) scrapie strain of sheep and goats. Using a highly sensitive murine mouse model (tg338) that overexpresses ovine PrP^C , we determined that this method of decontamination reduced the infectivity titre by 10¹⁰ . Infectivity was nonetheless still detected after applying the recommended autoclaving protocol. This shows that AS/Nor98 can survive the designated legislative decontamination conditions, albeit with a significant decrease in titre. The infectivity of a classical scrapie isolate subjected to the same decontamination conditions was reduced by 10⁶ suggesting that the AS/Nor98 isolate is less sensitive to decontamination than the classical scrapie source.

Molecular characterisation of atypical BSE prions by mass spectrometry and changes following transmission to sheep and transgenic mouse models

The prion hypothesis proposes a causal relationship between the misfolded prion protein (PrPSc) molecular entity and the disease transmissible spongiform encephalopathy (TSE). Variations in the conformation of PrPSc are associated with different forms of TSE and different risks to animal and human health. Since the discovery of atypical forms of bovine spongiform encephalopathy (BSE) in 2003, scientists have progressed the molecular characterisation of the associated PrPSc in order to better understand these risks, both in cattle as the natural host and following experimental transmission to other species. Here we report the development of a mass spectrometry based assay for molecular characterisation of bovine proteinase K (PK) treated PrPSc (PrPres) by quantitative identification of its N-terminal amino acid profiles (N-TAAPs) and tryptic peptides. We have applied the assay to classical, H-type and L-type BSE prions purified from cattle, transgenic (Tg) mice expressing the bovine (Tg110 and Tg1896) or ovine (TgEM16) prion protein gene, and sheep brain. We determined that, for classical BSE in cattle, the G96 N-terminal cleavage site dominated, while the range of cleavage sites was wider following transmission to Tg mice and sheep. For L-BSE in cattle and Tg bovinised mice, a C-terminal shift was identified in the N-TAAP distribution compared to classical BSE, consistent with observations by Western blot (WB). For L-BSE transmitted to sheep, both N-TAAP and tryptic peptide profiles were found to be changed compared to cattle, but less so following transmission to Tg ovinised mice. Relative abundances of aglycosyl peptides were found to be significantly different between the atypical BSE forms in cattle as well as in other hosts. The enhanced resolution provided by molecular analysis of PrPres using mass spectrometry has improved insight into the molecular changes following transmission of atypical BSE to other species.

Does the Presence of Scrapie Affect the Ability of Current Statutory Discriminatory Tests To Detect the Presence of Bovine Spongiform Encephalopathy?

Current European Commission (EC) surveillance regulations require discriminatory testing of all transmissible spongiform encephalopathy (TSE)-positive small ruminant (SR) samples in order to classify them as bovine spongiform encephalopathy (BSE) or non-BSE. This requires a range of tests, including characterization by bioassay in mouse models. Since 2005, naturally occurring BSE has been identified in two goats. It has also been demonstrated that more than one distinct TSE strain can coinfect a single animal in natural field situations. This study assesses the ability of the statutory methods as listed in the regulation to identify BSE in a blinded series of brain samples, in which ovine BSE and distinct isolates of scrapie are mixed at various ratios ranging from 99% to 1%. Additionally, these current statutory tests were compared with a new in vitro discriminatory method, which uses serial protein misfolding cyclic amplification (sPMCA). Western blotting consistently detected 50% BSE within a mixture, but at higher dilutions it had variable success. The enzyme-linked immunosorbent assay (ELISA) method consistently detected BSE only when it was present as 99% of the mixture, with variable success at higher dilutions. Bioassay and sPMCA reported BSE in all samples where it was present, down to 1%. sPMCA also consistently detected the presence of BSE in mixtures at 0.1%. While bioassay is the only validated method that allows comprehensive phenotypic characterization of an unknown TSE isolate, the sPMCA assay appears to offer a fast and cost-effective alternative for the screening of unknown isolates when the purpose of the investigation was solely to determine the presence or absence of BSE.